![](https://d3ilqtpdwi981i.cloudfront.net/Wl3D9o5zeKNv6PpF3nd0xLPUK5g=/0x0:624x808/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/fa/0f/5c/fa0f5c67-c395-4a2f-ba0a-b1e1d66b1943/BMC2.png)
Article
Prophylactic Pegfilgrastim to Prevent Febrile Neutropenia Among Patients Receiving Biweekly (Q2W) Chemotherapy Regimens: a Systematic Review of Efficacy, Effectiveness and Safety
BMC Cancer
(2021)
Disciplines
Publication Date
2021
Citation Information
Reshma Mahtani, Jeffrey Crawford, Sinéad M. Flannery, Tatiana Lawrence, et al.. "Prophylactic Pegfilgrastim to Prevent Febrile Neutropenia Among Patients Receiving Biweekly (Q2W) Chemotherapy Regimens: a Systematic Review of Efficacy, Effectiveness and Safety" BMC Cancer Vol. 21 Iss. 1 (2021) Available at: http://works.bepress.com/reshma-mahtani/96/